BACKGROUND: The vein of Marshall (VOM) is an attractive target during ablation of atrial fibrillation due to its autonomic innervation, its location anterior to the left pulmonary veins and drainage in the coronary sinus. METHODS AND RESULTS: We studied 17 dogs. A coronary sinus venogram showed a VOM in 13, which was successfully cannulated with an angioplasty wire and balloon. In 5 dogs, electroanatomical maps of the left atrium were performed at baseline and after ethanol infusion in the VOM, which demonstrated a new crescent-shaped scar, extending from the annular left atrium towards the posterior wall and left pulmonary veins. In 4 other dogs, effective refractory periods (ERP) were measured at 3 sites in the left atrium, before and after high-frequency bilateral vagal stimulation. The ERP decreased from 113.6+/-35.0 ms to 82.2+/-25.4 ms (p<0.05) after vagal stimulation. After VOM ethanol infusion, vagally-mediated ERP decrease was eliminated (from 108.6+/-24.1 ms to 96.4 +/-16.9ms, p=NS). The abolition of vagal effects was limited to sites near the VOM (ERP: 104+/-14 ms, vs 98.6+/-12.2 ms post vagal stimulation, p=ns), as opposed to sites remote to VOM (ERP: 107.2+/-14.9 ms, vs 78.6+/-14.7ms post vagal stimulation, p<0.05). To test feasibility in humans, 5 patients undergoing pulmonary vein antral isolation had successful VOM cannulation and ethanol infusion: left atrial voltage maps demonstrated new scar involving the infero-posterior left atrial wall extending towards the left pulmonary veins. CONCLUSIONS: Ethanol infusion in then VOM achieves significant left atrial tissue ablation, abolishes local vagal responses and is feasible in humans.
BACKGROUND: The vein of Marshall (VOM) is an attractive target during ablation of atrial fibrillation due to its autonomic innervation, its location anterior to the left pulmonary veins and drainage in the coronary sinus. METHODS AND RESULTS: We studied 17 dogs. A coronary sinus venogram showed a VOM in 13, which was successfully cannulated with an angioplasty wire and balloon. In 5 dogs, electroanatomical maps of the left atrium were performed at baseline and after ethanol infusion in the VOM, which demonstrated a new crescent-shaped scar, extending from the annular left atrium towards the posterior wall and left pulmonary veins. In 4 other dogs, effective refractory periods (ERP) were measured at 3 sites in the left atrium, before and after high-frequency bilateral vagal stimulation. The ERP decreased from 113.6+/-35.0 ms to 82.2+/-25.4 ms (p<0.05) after vagal stimulation. After VOM ethanol infusion, vagally-mediated ERP decrease was eliminated (from 108.6+/-24.1 ms to 96.4 +/-16.9ms, p=NS). The abolition of vagal effects was limited to sites near the VOM (ERP: 104+/-14 ms, vs 98.6+/-12.2 ms post vagal stimulation, p=ns), as opposed to sites remote to VOM (ERP: 107.2+/-14.9 ms, vs 78.6+/-14.7ms post vagal stimulation, p<0.05). To test feasibility in humans, 5 patients undergoing pulmonary vein antral isolation had successful VOM cannulation and ethanol infusion: left atrial voltage maps demonstrated new scar involving the infero-posterior left atrial wall extending towards the left pulmonary veins. CONCLUSIONS:Ethanol infusion in then VOM achieves significant left atrial tissue ablation, abolishes local vagal responses and is feasible in humans.
Entities:
Keywords:
ablation; atrial fibrillation; ethanol; vagal; vein of Marshall
Authors: C Knight; A S Kurbaan; H Seggewiss; M Henein; M Gunning; D Harrington; D Fassbender; U Gleichmann; U Sigwart Journal: Circulation Date: 1997-04-15 Impact factor: 29.690
Authors: Alex Y Tan; Chung-Chuan Chou; Shengmei Zhou; Motoki Nihei; Chun Hwang; C Thomas Peter; Michael C Fishbein; Peng-Sheng Chen Journal: Am J Physiol Heart Circ Physiol Date: 2005-09-09 Impact factor: 4.733
Authors: R N Doshi; T J Wu; M Yashima; Y H Kim; J J Ong; J M Cao; C Hwang; P Yashar; M C Fishbein; H S Karagueuzian; P S Chen Journal: Circulation Date: 1999-08-24 Impact factor: 29.690
Authors: T Sueda; K Imai; K Orihashi; H Shikata; S Wada; S Hirai; S Morita; Y Matsuura Journal: Ann Thorac Cardiovasc Surg Date: 1998-08 Impact factor: 1.520
Authors: Carlo Pappone; Hakan Oral; Vincenzo Santinelli; Gabriele Vicedomini; Christopher C Lang; Francesco Manguso; Lucia Torracca; Stefano Benussi; Ottavio Alfieri; Robert Hong; William Lau; Kirk Hirata; Neil Shikuma; Burr Hall; Fred Morady Journal: Circulation Date: 2004-05-24 Impact factor: 29.690
Authors: Frédéric Sacher; Piotr Sobieszczyk; Usha Tedrow; Andrew C Eisenhauer; Michael E Field; Andrew Selwyn; Jean-Marc Raymond; Bruce Koplan; Laurence M Epstein; William G Stevenson Journal: Heart Rhythm Date: 2007-09-19 Impact factor: 6.343
Authors: José L Báez-Escudero; Percy Francisco Morales; Amish S Dave; Christine M Sasaridis; Young-Hoon Kim; Kaoru Okishige; Miguel Valderrábano Journal: Heart Rhythm Date: 2012-03-07 Impact factor: 6.343
Authors: José L Báez-Escudero; Takehiko Keida; Amish S Dave; Kaoru Okishige; Miguel Valderrábano Journal: J Am Coll Cardiol Date: 2014-02-19 Impact factor: 24.094
Authors: Kalyanam Shivkumar; Olujimi A Ajijola; Inder Anand; J Andrew Armour; Peng-Sheng Chen; Murray Esler; Gaetano M De Ferrari; Michael C Fishbein; Jeffrey J Goldberger; Ronald M Harper; Michael J Joyner; Sahib S Khalsa; Rajesh Kumar; Richard Lane; Aman Mahajan; Sunny Po; Peter J Schwartz; Virend K Somers; Miguel Valderrabano; Marmar Vaseghi; Douglas P Zipes Journal: J Physiol Date: 2016-06-14 Impact factor: 5.182
Authors: Koji Higuchi; Mehmet Akkaya; Matthias Koopmann; Joshua J E Blauer; Nathan S Burgon; Kavitha Damal; Ravi Ranjan; Eugene Kholmovski; Rob S Macleod; Nassir F Marrouche Journal: Pacing Clin Electrophysiol Date: 2013-01-28 Impact factor: 1.976